Ten years experience in the treatment of Pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 725-728

  De Simone, Michele ^a   Vaira, M ^a   Caponi, A ^a   Ciaccio, B ^a   Fiorentini, G ^a   Turrisi, G ^a   Ferri, L ^a   Buti, G ^a  

^a SAN GIUSEPPE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Hyperthermia; Peritonectomy; Pseudomyxoma peritonei

Indexed keywords

CISPLATIN; MITOMYCIN C;

ABDOMINAL SURGERY; ABDOMINAL WALL DEFECT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIC THERAPY; INTESTINAL BLEEDING; INTESTINE PERFORATION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE COMPLICATION; REGIONAL PERFUSION; REOPERATION; SEPSIS; STENT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINARY TRACT FISTULA;

EID: 33846117638     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM et al: Pseudomyxoma peritonei syndrome. Adv Surg 30: 233-280, 1996.
2. Glehen O, Sugarbaker PH, Elias D, De Simone M et al: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer. A multi-institutional study for 506 patients. J Clin Oncol 22: 3284, 2004.
3. Sugarbaker PH and Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6(8): 727-731, 1999.
4. Averbach AM and Sugarbaker PH: Methodologic considerations in treatment using intraperitoneal chemotherapy. Cancer Treat Res 82: 289-309, 1996.
5. Cavaliere F, Perri P, Di Filippo F, Giannarelli D et al: Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 74(1): 41-44, 2000.
6. Gilly FN, Carry PY, Sayag AC, Brachet A et al: Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41(2): 124-129, 1994.
7. Loggie BW, Fleming RA, McQuellon RP, Russell GB et al: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66(6): 561-568, 2000.
8. De Simone M and Vaira M: Cytoreduction, peritonectomy and hyperthermic antiblastic peritoneal perfusion for the treatment of peritoneal carcinomatosis. In: Hyperthermia in Cancer Treatment: A Primer. Baronzio GF and Hager D (eds.). Eurekah.com and Springer Science+Business Media-U.S.A., 2006.
9. De Simone M, Barone R, Vaira M, Aghemo B et al: Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis. J Surg Oncol 82(2): 138-140, 2003.
10. Elias D, Antoun S, Raynard B, Pulzillout JM et al: Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures. Chirurgie 124(4): 380-389, 1999.
11. Verwaal F et al: Treatment of peritoneal carcinomatosis from colorectal cancer with hyperthermic antiblastic peritoneal perfusion. J Clin Oncol 21: 3737, 2003.
12. Fernandez RN and Daly JM: Pseudomyxoma peri-tonei. Arch Surg 115: 409-414, 1980.